FdaApplication

ANDA 213369

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAPOTEX INC
application_typeANDA
approval_date2023-07-13

Products (3)

ProductActive ingredientStrengthDosage form
OXCARBAZEPINEOXCARBAZEPINE150MGTABLET, EXTENDED RELEASE;ORAL
OXCARBAZEPINEOXCARBAZEPINE300MGTABLET, EXTENDED RELEASE;ORAL
OXCARBAZEPINEOXCARBAZEPINE600MGTABLET, EXTENDED RELEASE;ORAL

3 products